Retargeted adenoviruses for local IgA and CD47 blocker production as a novel cancer therapy
Mariya Chernyavska, Karen Patricia Hartmann, Marco Jansen, Niklas Baumann, Jonas Kolibius, Dominik Brücher, Theodora Kristoforus, R.W. Peters, Lucas Huijs, Daphne Laarveld, Fabian Weiss, Renate Burger, Marta Lustig, Nadine Gimenez de Assis, Markus Schmid, , Wouter P. R. Verdurmen
This paper develops a retargeted adenovirus system to produce IgA antibodies and CD47 blockers in tumors, enhancing innate immune responses and reducing tumor volume in mice.
EMBO Molecular Medicine · Jul 7, 2026Peer-reviewedImmunology